Timothy Patrick Flynn Buys 1,000 Shares of UnitedHealth Group Incorporated (NYSE:UNH) Stock

UnitedHealth Group Incorporated (NYSE:UNH) Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

UnitedHealth Group Price Performance

UNH opened at $528.94 on Friday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $486.77 billion, a price-to-earnings ratio of 34.12, a PEG ratio of 1.42 and a beta of 0.62. The company has a fifty day simple moving average of $543.52 and a 200 day simple moving average of $563.78.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The company’s revenue was up 6.8% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.75 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.59%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

UNH has been the topic of several recent research reports. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Finally, Morgan Stanley cut their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $627.74.

Hedge Funds Weigh In On UnitedHealth Group

A number of hedge funds have recently bought and sold shares of the company. Custom Index Systems LLC grew its position in shares of UnitedHealth Group by 5.1% in the 4th quarter. Custom Index Systems LLC now owns 929 shares of the healthcare conglomerate’s stock worth $470,000 after acquiring an additional 45 shares in the last quarter. Heck Capital Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at $1,649,000. Austin Private Wealth LLC lifted its position in shares of UnitedHealth Group by 16.4% in the 4th quarter. Austin Private Wealth LLC now owns 2,811 shares of the healthcare conglomerate’s stock worth $1,422,000 after buying an additional 396 shares during the last quarter. West Bancorporation Inc. grew its position in shares of UnitedHealth Group by 9.3% during the 4th quarter. West Bancorporation Inc. now owns 679 shares of the healthcare conglomerate’s stock valued at $343,000 after buying an additional 58 shares during the last quarter. Finally, Hamilton Point Investment Advisors LLC lifted its holdings in UnitedHealth Group by 324.0% in the fourth quarter. Hamilton Point Investment Advisors LLC now owns 1,747 shares of the healthcare conglomerate’s stock worth $884,000 after acquiring an additional 1,335 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.